Morepen Laboratories share news, announcements and annual reports
NSE: MOREPENLABBSE: 500288Pharmaceuticals & BiotechnologySmall Cap
Share price at the NSE close on 30 Oct 2026. Previous close ₹119.31.
30 Oct: open ₹113.35, high ₹122.23, low ₹113.35
- Under NSE's long-term additional surveillance, stage IV, on the list for 30 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Delivery only: shares bought must be paid for in full, with no selling on the same day.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹6,211 Cr1,108th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 32.94
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 4.50
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.18%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 14.6%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 14.3%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.22
- Volume, NSEVolume. Shares traded on the last trading day. Volume in the glossary
- 88,57,838
Morepen Laboratories share news and announcements
608 announcements, routine notices left out, newest first. Page 7 of 13.
Feb 2021
12 Feb · Results
5 Feb · Board meeting
Jan 2021
Dec 2020
3 Dec · Related Party Transactions
Nov 2020
17 Nov · Analysts
9 Nov · Results
9 Nov · Board meeting
7 Nov · Analysts
Oct 2020
10 Oct · Board meeting
7 Oct · Board meeting
Sep 2020
30 Sep · Meeting
5 Sep · Updates
Aug 2020
31 Aug · Results
31 Aug · Board meeting
31 Aug · Analysts
24 Aug · Board meeting
Jul 2020
10 Jul · Related Party Transactions
Jun 2020
24 Jun · Analysts
22 Jun · Amendment to AOA/MOA
22 Jun · Increase in Authorised Capital
22 Jun · Results
18 Jun · Legal
The exchange asked on 17 Jun 2020
15 Jun · Board meeting
May 2020
Apr 2020
8 Apr · Legal
The exchange asked on 8 Apr 2020
Mar 2020
11 Mar · Updates
Feb 2020
14 Feb · Board meeting
14 Feb · Results
7 Feb · Board meeting
Jan 2020